본문 바로가기
KERD
논문KCI 등재후보

국내 의약품 경제성평가의 연구 방법과 활용에 대한 고찰

Review of Pharmaceutical Economic Evaluation Studies in Korea

2

조회

0

다운로드

0

인용

0

참고문헌

초록

Objectives: To analyze and evaluate pharmaceutical economic evaluation studies which have been published in Korea since 2007. Methods: Based on a comprehensive search for pharmaceutical economic evaluation researches, we selected 31 papers. And we analyzed those papers according to the research structure, process, and outcome. Results: 26 out of 31 papers were done for the after-reimbursed pharmaceutical. Most researches were done according to the economic evaluation guideline which was updated in 2011. But time horizon, data search and quality assessment, cost identification, equity, and budget impact analysis provisions in the guideline were not abided by in many papers. Conclusion: In order to help with allocation of scarce resource, it is necessary to derive valid results from pharmaceutical

Abstract

Objectives: To analyze and evaluate pharmaceutical economic evaluation studies which have been published in Korea since 2007. Methods: Based on a comprehensive search for pharmaceutical economic evaluation researches, we selected 31 papers. And we analyzed those papers according to the research structure, process, and outcome. Results: 26 out of 31 papers were done for the after-reimbursed pharmaceutical. Most researches were done according to the economic evaluation guideline which was updated in 2011. But time horizon, data search and quality assessment, cost identification, equity, and budget impact analysis provisions in the guideline were not abided by in many papers. Conclusion: In order to help with allocation of scarce resource, it is necessary to derive valid results from pharmaceutical

참고문헌 (13)

  1. 최용준, "우리나라 의약품 비용-효과 분석 연구의 현황", 보건경제와 정책연구, 9, pp.59~77 (2003)
  2. 이건세, "보건의료 경제성 평가 방법론 고찰 - 연구 설계와 비용 추정을 중심으로 -", 보건행정학회지, 14(2), pp.58~77 (2004), 한국보건행정학회
  3. 최상은, "의약품 보험급여 결정을 위한 경제성평가 연구의 평가", 보건행정학회지, 15(4), pp.1~25 (2005), 한국보건행정학회
  4. 보험 의약품 경제성 평가 가이드라인 개정방안 연구, "건강보험심사평가원", 건강보험심사평가원, ~ (2012)
  5. 이의경, "의약품 경제성평가 수행에 관한 인식도 조사 분석", 약 학 회 지, 51(6), pp.424~429 (2007), 대한약학회
  6. 신상진, "국내 질병비용 및 경제성 평가에서 비용 산출에 대한 고찰", 보건경제와 정책연구, 19(1), pp.77~92 (2013), 한국보건경제정책학회
  7. Norman R, "International comparisons in valuing EQ-5D health states: a review and analysis", Value in Health, 12, pp.1194~1200 (2009)
  8. 배은영, "의료기술평가를 통한 급여결정의 한계와 극복방안: 기등재의약품목록정비 사업에 대한 평가를 중심으로", 보건경제와 정책연구, 16(3), pp.163~187 (2010), 한국보건경제정책학회
  9. 박정애, "우울증 치료 시 항우울제 선택에 관한 비용-효과 분석", 석사, 사회약학, pp.2010
  10. 김윤희, "건강개선 정도에 따른 지불의사금액 추정 연구", 보건경제와 정책연구, 16(2), pp.79~100 (2010), 한국보건경제정책학회
  11. 이의경, "주요국 의약품 경제성 평가제도의 시사점과 국내 제도 개선방안", 한국보건행정학회 학술대회 논문집, pp.67~86 (2008)
  12. Towse A, "Cost-effectiveness thresholds: economic and ethical issues" (2002), King’s Fund
  13. Olsen JA, "The insensitivity of ʻwillingness-to-pay’ to the size of the good: new evidence for health care", Journal of Economic Psychology, 25, pp.445~460 (2004)

관련 논문AI추천

이 간행물의 다른 논문 (8건)